| Pneumonia and Respiratory Infections | Lifetime | 6 | DE 1 | 99.91 |
| COVID-19 Clinical Research Studies | Lifetime | 66 | DE 5 | 99.55 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 37 | DE 2 | 99.60 |
| Transplantation: Methods and Outcomes | Lifetime | 38 | DE 5 | 99.56 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | Lifetime | 68 | DE 5 | 99.68 |
| Nosocomial Infections in ICU | Lifetime | 20 | DE 2 | 99.73 |
| Respiratory Support and Mechanisms | Lifetime | 92 | DE 7 | 99.64 |
| Respiratory viral infections research | Lifetime | 77 | DE 3 | 99.61 |
| Long-Term Effects of COVID-19 | Lifetime | 88 | DE 4 | 98.94 |
| Sepsis Diagnosis and Treatment | Lifetime | 131 | DE 5 | 99.30 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 175 | DE 14 | 98.90 |
| Asthma and respiratory diseases | Lifetime | 416 | DE 32 | 98.98 |
| Pediatric health and respiratory diseases | Lifetime | 182 | DE 10 | 98.65 |
| Respiratory and Cough-Related Research | Lifetime | 172 | DE 11 | 98.91 |
| Emergency and Acute Care Studies | Lifetime | 260 | DE 4 | 98.39 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 280 | DE 19 | 98.49 |
| Antibiotics Pharmacokinetics and Efficacy | Lifetime | 352 | DE 18 | 98.25 |
| Protease and Inhibitor Mechanisms | Lifetime | 298 | DE 19 | 97.93 |
| Cystic Fibrosis Research Advances | Lifetime | 296 | DE 16 | 97.50 |
| Antibiotic Resistance in Bacteria | Lifetime | 740 | DE 31 | 97.97 |
| Intensive Care Unit Cognitive Disorders | Lifetime | 578 | DE 21 | 97.27 |
| Antibiotic Use and Resistance | Lifetime | 574 | DE 11 | 96.65 |
| Airway Management and Intubation Techniques | Lifetime | 949 | DE 53 | 95.30 |
| Health and Medical Studies | Lifetime | 972 | DE 835 | 89.77 |
| Inflammation biomarkers and pathways | Lifetime | 938 | DE 69 | 68.84 |
| Pneumothorax, Barotrauma, Emphysema | Lifetime | 999 | DE 40 | 64.58 |
| COVID-19 Clinical Research Studies | 2021-2025 | 124 | DE 3 | 99.30 |
| Respiratory Support and Mechanisms | 2021-2025 | 69 | DE 4 | 98.96 |
| Pneumonia and Respiratory Infections | 2021-2025 | 54 | DE 1 | 98.34 |
| Long-Term Effects of COVID-19 | 2021-2025 | 182 | DE 7 | 97.80 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | 2021-2025 | 88 | DE 5 | 98.46 |
| Respiratory viral infections research | 2021-2025 | 102 | DE 1 | 97.71 |
| Asthma and respiratory diseases | 2021-2025 | 202 | DE 19 | 98.11 |
| Sepsis Diagnosis and Treatment | 2021-2025 | 447 | DE 18 | 93.44 |
| Transplantation: Methods and Outcomes | 2021-2025 | 360 | DE 14 | 93.16 |
| Nosocomial Infections in ICU | 2021-2025 | 153 | DE 6 | 90.36 |
| Pediatric health and respiratory diseases | 2021-2025 | 194 | DE 11 | 88.49 |
| Respiratory and Cough-Related Research | 2021-2025 | 300 | DE 16 | 90.36 |
| Pneumocystis jirovecii pneumonia detection and treatment | 2021-2025 | 576 | DE 13 | 83.50 |
| Cystic Fibrosis Research Advances | 2021-2025 | 838 | DE 53 | 84.04 |
| Medical Imaging and Pathology Studies | 2021-2025 | 742 | DE 36 | 76.72 |
| Protease and Inhibitor Mechanisms | 2021-2025 | 292 | DE 42 | 77.56 |
| Inhalation and Respiratory Drug Delivery | 2021-2025 | 825 | DE 28 | 75.96 |
| Thermal Regulation in Medicine | 2021-2025 | 533 | DE 29 | 66.14 |
